BUSINESS
F&O manual | Some recovery is visible but traders suggest to wait for long addition
Most sectoral indices also traded in the green which suggests that recovery in the market is broad based.
BUSINESS
Know your stock | Is there a glimmer of hope for SeQuent Scientific?
The stock has witnessed a consistent decline since testing its record high in July 2021. Since then, the stock has plunged around 76% on the back of declining profits.
BUSINESS
F&O Manual: Write calls at higher strike prices for Nifty, analysts say
The Nifty witnessed selling for the fourth consecutive session today amid weak cues from global markets which saw the index even slipped below 17,000 intraday.
BUSINESS
Krsnaa Diagnostics shares soar on network expansion
The company is also preparing to open new centers in Uttar Pradesh, Delhi, Maharashtra, and Rajasthan.
BUSINESS
F&O Manual: Initiate bearish put spread on Bank Nifty as setup remains weak, say analysts
The Nifty witnessed strong selling pressure as it broke below the Budget day low of around 17,250 points and accordingly, analysts predict more weakness hereon.
BUSINESS
Analyst Call Tracker: Why do analysts favour Titan even as investors lose interest in the stock?
AK Prabhakar of IDBI Capital Markets & Securities says a slight correction in Titan's valuation towards Rs 2,000 can make it an excellent addition to investor portfolios
BUSINESS
Analyst Call Tracker: Why Dr Reddy's acquisition of Maynes Pharma failed to cheer analysts?
Buy calls slipped to 31 from 33 for Dr Reddy's Laboratories as ‘hold’ and ‘sell’ ratings climbed one each over February to a combined total of 11. The stock added a meagre 2 percent during the month.
BUSINESS
Analyst Call Tracker: Why three auto stocks are winning over analysts amid price volatility?
Bajaj Auto, Tata Motors and Mahindra & Mahindra were among 10 stocks with the maximum contrarian calls even as investors booked profits in them in February.
BUSINESS
SeQuent Scientific zooms 20% on terminating Tineta Pharma acquisition
The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021.
BUSINESS
Navy Ramavat of Indira Securities predicts sustainable rebound for Nifty
Ramavat has expressed bullishness on several sectors, including capital goods, railways, PSU banks, and information technology. He sees potential for growth and investment opportunities in these sectors.
BUSINESS
Trader's Mela 2023: Sentiment seen cautiously optimistic this week
Most traders pegged a resistance at 17,800 points followed by 18,000, but expect the upside to be gradual, filled with bouts of small corrections.
BUSINESS
Bajaj Electricals shares gain on bagging order worth Rs 564 crore
The company's engineering and procurement segment had an order book of approximately Rs 1,200 crore in Q3.
BUSINESS
Adani Green's operating renewable portfolio reaches 8,024 MW; stock in upper circuit
Adani Green's fourth wind-solar hybrid power plant, which has a generation capacity of 700 MW, got operational in Rajasthan's Jaisalmer, the company has said
BUSINESS
Contrarian calls | Profit-booking drags automobile firms but analysts bullish on sector
Withering sentiment among retail investors and FIIs moving to China added to the woes for Indian equities in February but analysts continue to be upbeat about some stocks, take a look
BUSINESS
Railway stocks surge on lowest bid for Vande Bharat trains
A consortium of Rail Vikas Nigam and Russia's CJSC Transmashholding emerged as the lowest bidder while Titagarh Wagons and Bharat Heavy Electricals placed the second lowest bid.
BUSINESS
ZEE breaks 6-day losing streak, surges 7%, as NSE issues fresh F&O contracts
Last week, the exchange had declared that it would not issue any new month futures and options (F&O) contracts once the contracts for February expired.
BUSINESS
Small pharma cos curtailing investments in the US, says Jefferies
Failure to capture market share, supply disruptions from non-compliance of current good manufacturing practices imposed by the US Food and Drugs Administration are some of the reasons triggering the move.
BUSINESS
Sanofi India shares clock biggest intraday gain in 7 months on robust bottomline
Elara Capital gave a Buy call for the stock as it sees an upside potential of 26%
BUSINESS
Is network expansion the booster dose diagnostic firms need?
Experts are bullish about the sector, and cite multiple tailwinds that would help drive growth, including increasing health awareness, potential industry consolidation, and more.
BUSINESS
ShareKhan has a 'neutral' stance on pharma companies; here's why
The brokerage firm has given 'buy' or 'hold' calls to 13 out of the total 16 companies in its pharmaceutical coverage
BUSINESS
SpiceJet shares inch higher ahead of Q3 earnings, board meet
Reports have suggested that Carlyle Aviation Partners, a leasing firm owned by global private equity giant Carlyle Group, may convert its rental dues into equity, obtaining a 5 percent stake in the low-cost carrier
BUSINESS
Price hikes are changing the game for diagnostic cos; here's how analysts see it
New-age entities are aggressively marketing low-price tests to attract attention but are also raising prices of select preventive packages as their focus shifts towards profitability.
BUSINESS
HG Infra gains on winning Rs 466-crore RVNL project
Brokerage firm ICICIdirect expects recent order inflows to improve the revenue visibility for HG Infra Engineering
BUSINESS
Easing margin pressures, uptick in US sales saving grace for pharma firms in Q3
Despite moderation in margin pressure, a rise in input costs for some medications can derail pharma sector's recovery, say analysts
